Gary B. Abromovitz

Gary B. Abromovitz, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Helen of Troy Ltd and CardioVascular BioTherapeutics, Inc. Over a trading history stretching from 11 February 2005 to 1 June 2022, the count stands at 79 filings.

The open-market side counts 1 purchase alongside 16 sales for €2.3M. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 50 share grants and 12 option exercises. Since January 2022: no purchases and 1 sale on the market.

The record was last updated on 3 June 2022 with a share grant in Helen of Troy Ltd. The last insider purchase was made public on 27 February 2007, 7,194 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.